全文获取类型
收费全文 | 18316篇 |
免费 | 1272篇 |
国内免费 | 370篇 |
专业分类
耳鼻咽喉 | 214篇 |
儿科学 | 293篇 |
妇产科学 | 1872篇 |
基础医学 | 1652篇 |
口腔科学 | 308篇 |
临床医学 | 1864篇 |
内科学 | 1044篇 |
皮肤病学 | 147篇 |
神经病学 | 375篇 |
特种医学 | 213篇 |
外科学 | 1233篇 |
综合类 | 1653篇 |
现状与发展 | 4篇 |
一般理论 | 1篇 |
预防医学 | 1426篇 |
眼科学 | 774篇 |
药学 | 5850篇 |
22篇 | |
中国医学 | 516篇 |
肿瘤学 | 497篇 |
出版年
2024年 | 14篇 |
2023年 | 358篇 |
2022年 | 406篇 |
2021年 | 709篇 |
2020年 | 641篇 |
2019年 | 718篇 |
2018年 | 814篇 |
2017年 | 771篇 |
2016年 | 802篇 |
2015年 | 804篇 |
2014年 | 1166篇 |
2013年 | 2724篇 |
2012年 | 921篇 |
2011年 | 1111篇 |
2010年 | 733篇 |
2009年 | 948篇 |
2008年 | 891篇 |
2007年 | 761篇 |
2006年 | 670篇 |
2005年 | 580篇 |
2004年 | 536篇 |
2003年 | 401篇 |
2002年 | 329篇 |
2001年 | 244篇 |
2000年 | 243篇 |
1999年 | 189篇 |
1998年 | 162篇 |
1997年 | 143篇 |
1996年 | 146篇 |
1995年 | 139篇 |
1994年 | 111篇 |
1993年 | 117篇 |
1992年 | 98篇 |
1991年 | 72篇 |
1990年 | 76篇 |
1989年 | 62篇 |
1988年 | 39篇 |
1987年 | 29篇 |
1986年 | 48篇 |
1985年 | 48篇 |
1984年 | 32篇 |
1983年 | 34篇 |
1982年 | 25篇 |
1981年 | 20篇 |
1980年 | 15篇 |
1979年 | 17篇 |
1978年 | 13篇 |
1977年 | 10篇 |
1975年 | 3篇 |
1974年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
91.
92.
BackgroundCesarean delivery is one of the most common surgeries performed worldwide and the adoption of enhanced recovery programs for cesarean delivery is gaining popularity. We tested the hypothesis that implementation of an enhanced recovery program for cesarean delivery would be associated with a decrease in postoperative opioid consumption.MethodsWe compared a retrospective cohort of women delivered by elective cesarean delivery (January 1, 2017 to June 30, 2018) to a prospective cohort exposed to the enhanced recovery protocol (July 1, 2018 to December 31, 2018). The primary outcome was inpatient maternal opioid use, measured as total oral morphine equivalents. Secondary outcomes included postoperative 0–10 pain scores, length of stay, 30-day postoperative complication rates, and hospital re-admissions.ResultsData from 541 patients were analyzed. The enhanced recovery cohort used significantly less oral morphine equivalents compared with the pre-enhanced recovery cohort (60.3 mg vs 104.3 mg, P <0.001). The number of patients who required opioid medication within 24 h of discharge was significantly reduced in the enhanced recovery cohort (41.1% vs 74.6%, P <0.001). There were no significant differences in average pain scores (1.6 vs 1.9, P=0.037).ConclusionsThe implementation of an enhanced recovery program for cesarean delivery was associated with a significant reduction in postoperative opioid consumption throughout hospitalization, with average pain scores remaining <2. Implementation of this program was also associated with an increase in the number of patients who were opioid-free 24 h prior to discharge. 相似文献
93.
近年来癌症治疗受到广泛关注,二氧化硅纳米颗粒因其独特的理化性质在肿瘤诊疗领域展现巨大潜力。基于二氧化硅纳米粒子的药物输送系统可被动或主动靶向肿瘤组织,并通过刺激响应的方式实现药物在肿瘤部位的可控释放,有效提高抗肿瘤药物在肿瘤部位的浓度,提高治疗效率。同时,二氧化硅纳米粒子通过负载造影剂可实现生物成像功能,用于肿瘤组织定位及药物追踪,实现更高效的抗肿瘤治疗。本文介绍了二氧化硅纳米粒子的制备方式,并对二氧化硅纳米粒子在药物靶向递送系统及生物成像领域中的研究进展进行综述。 相似文献
94.
Caroline E. Sloan Judy Zhong Dinushika Mohottige Rasheeda Hall Clarissa J. Diamantidis Leight E. Boulware Virginia Wang 《Seminars in dialysis》2020,33(6):440-448
Caring for patients with end-stage kidney disease (ESKD) in the United States is challenging, due in part to the complex epidemiology of the disease's progression as well as the ways in which care is delivered. As CKD progresses toward ESKD, the number of comorbidities increases and care involves multiple healthcare providers from multiple subspecialties. This occurs in the context of a fragmented US healthcare delivery system that is traditionally siloed by provider specialty, organization, as well as systems of payment and administration. This article describes the role of care fragmentation in the delivery of optimal ESKD care and identifies research gaps in the evidence across the continuum of care. We then consider the impact of care fragmentation on ESKD care from the patient and health system perspectives and explore opportunities for system-level interventions aimed at improving care for patients with ESKD. 相似文献
95.
目的 分析白内障围手术期结膜囊菌群的分布及药敏试验结果。方法 选取264例白内障患者,分别在患者入院后、手术消毒前、手术消毒后、手术结束后四个时间点取样,进行细菌培养及药敏试验,比较不同时期的细菌培养结果和药敏结果。结果 入院后结膜囊细菌培养阳性率明显高于手术消毒前、手术消毒后及手术结束后;入院后结膜囊细菌培养以表皮葡萄球菌为主;革兰氏阳性球菌对头孢西丁、加替沙星、左氧氟沙星等敏感性较高。结论 表皮葡萄球菌是结膜囊最常见的细菌,术前应常规应用抗生素点眼,聚维酮碘冲洗结膜囊等来预防术后感染性眼内炎。 相似文献
96.
97.
98.
《Biomaterials》2015
Bacterial infection of subcutaneous “pockets” housing cardiovascular implantable electronic devices is a significant clinical complication. In this study, pacemakers encapsulated in a blood plasma-based material (PBM) composited with antibiotics were investigated for use as prophylactics against such infections. PBMs, which are made from pooled allogeneic plasma and platelets, are off-the-shelf biomaterials that can be manufactured in the form of complex 3D shapes, extrudable putties, or injectable pastes. In vitro studies with PBM pastes formulated with rifampicin and minocycline demonstrated antibiotic release over 6 days, activity against Escherichia coli, and reduced cytotoxic effects of the antibiotics on fibroblasts. The materials were also evaluated in vivo in a rabbit model in which pacemaker pockets were inoculated with methicillin-resistant Staphylococcus aureus (S. aureus) strain and examined 1 week later. The pockets containing the pacemaker plus S. aureus were grossly purulent and culture positive, whereas pockets into which PBM with antibiotics were injected around the pacemaker were free of purulence and culture negative (p < 0.001). None of the pockets into which PBM without antibiotics were placed demonstrated purulence, but 60% were culture positive. These results demonstrate the potential of PBMs to deliver antibiotics to diminish the incidence of pocket infections for pacemakers and other implantable devices. 相似文献
99.
100.